1. Introduction
Annexin A1, a protein previously termed as lipomodulin and lipocortin, is a member of the protein family that binds to phospholipids in a Ca2+ dependent manner (Hirata, 1998; Gerke & Moss, 2002; Lim & Pervaiz, 2007). This protein was first discovered as a phospholipase A2 inhibitory protein, and from its chemical nature was thought to be closely associated with membrane functions such as membrane organization, trafficking and metabolism (Hirata, 1998; Gerke & Moss, 2002; Lim & Pervaiz, 2007). On the other hand, annexin A1 is a major substrate of oncogenic kinases such as c-met and c-src, and is thus, proposed to be involved in signal transduction of growth factors and mitogens (Hirata et al., 1984; Skouteris & Schröder, 1996). Therefore, this protein is thought to have some regulatory roles in cancer development. Indeed, certain types of cancers such as hepatoma and pancreas cancers have higher levels of annexin A1 (Lim & Pervaiz, 2007). However, transfection of cDNA encoding annexin A1 often results in apoptosis of cells or interference of cell proliferation, consistent with tumor suppressing functions (Debret et al., 2003; Hsiang et al., 2006). In keeping with this interpretation, some types of cancers such as esophageal carcinoma and prostate cancer have decreased levels of annexin A1 (Lim & Pervaiz, 2007). However, recent pathohistochemical evidence with esophageal carcinoma and neck squamous carcinoma suggests that such down-regulation of annexin A1 is partially attributed to nuclear translocation, and the nuclear translocation of annexin A1 is facilitated by tyrosine and/or serine phosphorylation and Ca2+ signals as well as by oxidative stress (Rhee et al., 2000; Kim et al., 2003; Liu et al., 2003; Cui et al., 2007; Lin et al., 2008). The presence of annexin A1 in nuclei is now proposed to be a poor prognostic marker of squamous cancer or to be associated with malignancy of gastric carcinoma, while changes in cellular expression of annexin A1 may not be involved in tumorigenesis (Lin et al., 2008; Zhu et al., 2010). Therefore, nuclear annexin A1 is thought to play an important role in cell proliferation and/or cell transformation. Since this protein is reported to reside on DNA synthesomes within nuclei (Lin et al., 1997), it is likely that nuclear annexin A1 is involved in DNA replication, especially DNA damage induced gene mutation, since DNA damage induced mutagenesis plays an important role in tumorigenesis.
Mutagenesis is largely the outcome of insults to DNA by environmental agents including alkylating agents and by endogenous metabolic oxidative metabolites such as reactive oxygen, and plays an important role in initiation, progression, and ultimately formation of cancer (Wang, 2001). Heavy metals such as As3+ are known to promote the mutagenic action of another DNA damaging agent including reactive oxygen, while they alone are weakly- or non-mutagenic (Sekowski et al., 1997; Maier et al., 2002). Such promotion by heavy metals is attributed not only to inhibition of DNA repair systems such as mismatch repair but also to relaxation of the semi-conservative replication machinery for translesion DNA synthesis that bypasses sites of damage (Calsou et al., 1996; Jin et al., 2003). Translesion DNA synthesis is catalyzed by error-prone DNA polymerases, and exchange of DNA polymerases is promoted by ubiquitination of nuclear proteins such as proliferating cell nuclear antigen (PCNA) (Ulrich, 2005). Translesion DNA synthesis is thought to be the major cause of mutagenesis rather than incorrect repair of damaged DNA (Kunz et al., 2000). Accordingly, we have investigated how annexin A1 in nuclei stimulates DNA damage-induced mutagenesis.
2. Modifications of annexin A1 in nuclei with ubiquitin and ubiquitin-like proteins
Ubiquitin and ubiquitin-like modification systems are related pathways that covalently attach a protein modifier to a lysine residue of a target protein. Ubiquitin classically marks proteins for proteosomal destruction typically when polymeric chains (longer than four ubiquitin subunits) assemble
Since annexin A1 contains the consensus sequence, ψΚxE/D, for SUMOylation, purified bovine annexin A1 was incubated with human recombinant Ubc9 (E2) and SAE I/SAE II (E1) in the presence of SUMO 1, 2 or 3 to test whether annexin A1 can be SUMOylated. When the reaction mixtures were analyzed by Western blots, monospecific anti-SUMO antibodies stained two proteins with apparent molecular weights around 38,000 and 34,000 Da (F. Hirata et al., 2010). Anti-annexin A1 antibody detected a broad single protein band with an apparent molecular weight around 37,000 Da but not a protein band with a molecular weight of 34,000 Da. The protein band with a molecular weight of 34,000 was identified, using anti-Ubc9 antibody as SUMOylated Ubc9 (F. Hirata et al., 2010). With SUMO 2 or 3 as a substrate, SUMOylation of annexin A1 was apparently facilitated. Rates of annexin A1 SUMOylation with SUMO 1, 2 or 3 were approximately 1:3:5, providing that the amounts of SUMOylated Ubc9 formed with SUMO 1, 2, or 3 were essentially the same. Ca2+ was required for the maximal modification, and increased SUMOylation by 2.6 fold
On the other hand, the molecular weight of annexin A1 shifted from 37,000 Da to approximately 45,000 Da after ubiquitination. The ubiquitination of annexin A1 required UbcH2A (Rad6 homologue) together with HeLa S100 lysate that contained E3 ubiquitin ligases. Since HeLa S100 lysate pretreated with anti-Rad 18 antibody did not catalyze ubiquitination of annexin A1, it is most likely that Rad18 is an E3 ligase for ubiquitination of annexin A1. Ca2+ was required for the maximal ubiquitination, but its stimulation was not as much as seen with SUMOylation, when amounts of ubiquitinated annexin A1 were adjusted with the total amounts of annexin A1 (free and ubiquitinated annexin A1). These observations suggest that the modification site with ubiquitin is distinct from that with SUMO. HeLa S100 lysate also contained annexin A1 as detected by anti-annexin A1 antibody, but under the present experimental conditions, no significant ubiquitination of endogenous annexin A1 was detected in the presence of ubiquitin and an ATP generating system without UbcH2A. UbcH2A could be equally replaced by its related enzyme, UbcH2B but not by E2-25K. These observations suggest but do not necessarily prove that annexin A1 is ubiquitinated by the Rad6–Rad18 system which is closely associated with response to DNA damage (Kunz et al., 2000; Ulrich, 2005). The difference in stimulation of SUMO and ubiquitin conjugation by Ca2+ is apparently attributed to sites of modification and Ca2+ induced conformational changes, in which the N-terminal domain is exposed and flexibility of the core domain residues are increased by Ca2+ (Shesham et al., 2008). Therefore, we suggest that SUMOylation takes place in the core domain regions, while ubiquitination takes place outside the core domain regions.
3. DNA damage and modification of annexin A1
Among post-translational modification systems, ubiquitin and ubiquitin-like molecules including SUMO are a unique family of protein modifiers that play pivotal roles in regulation of protein stability and function (Hicke, 2001; Gill, 2004; Hilgarth et al., 2004; Huang & D’Andrea, 2006; Chen & Sun, 2009). SUMOylation is involved in protein stabilization, nucleo-cytoplasmic trafficking, cell cycle regulation, maintenance of genome integrity and transcription. Indeed, annexin A1 present in nuclei is mostly modified with SUMO or ubiquitin (F. Hirata et al., 2010). SUMO 1-modified annexin A1 resulted in enhanced helicase activity, while SUMO2/3 were the better substrates for
To ask whether mono-ubiquitination of annexin A1 is, indeed, involved in DNA damage response, we investigated if nuclear annexin A1 is modified with SUMO or ubiquitin in mouse L5178Y
4. DNA helicase activity of nuclear annexin A1
Annexins have a common internal structure comprising 4 or 8 repeats of a conserved 70 amino acid domain, and differ primarily in the length and composition of the amino-terminal domains (F. Hirata, 1998; Gerke and Moss, 2002; Lim and Pervaiz, 2007). Since this amino-terminal domain contains the sites for phosphorylation and glycosylation, it is considered a regulatory domain. A defining feature of annexins is their ability to bind, in a Ca2+-dependent manner, to negatively charged phospholipids such as phosphatidylserine (PtdSer). This functional feature is attributed to the conserved C-terminal domain, and is essential for biological functions of the annexins. The cell-cycle dependent existence of annexin A1 and A2 in nuclei suggests a close association with nuclear functions, while they are major substrates of the oncogenic tyrosine kinases, met and src (Katoh et al., 1995; Rydal et al., 1992). Thus, annexin A1 and A2 are proposed to be a biological marker of proliferating cells (cancer cells) (Masaki et al., 1994). In accord with this notion, the treatments of A347 and HeLa cells with antisense annexin A1 and A2 oligonucleotides reduce the synthesis and subsequent phosphorylation at tyrosine of the annexins, thereby inhibiting cell proliferation (Kumble et al., 1992; Skouteris & Schröder, 1996). Translocation of annexins from cytosol to nuclei apparently requires their phosphorylation at tyrosine and Ca2+ signaling (Mohiti et al., 1997). Purified annexin A1 and A2 can stimulate DNA synthesis in cell free systems of HeLa cells, Xenopus oocytes and rat hepatocytes (Vishwanatha & Kumble, 1992; Vishwanatha et al., 1992; Tavokoli-Nezhad et al., 1998). In addition, annexin A1 is present in DNA synthesomes and annexin A2 is located in nuclear matrix (Kumble et al, 1992; Lin et al., 1997). These observations strongly suggest that nuclear annexins regulate DNA replication.
Annexin A2 functions in DNA replication as a primer recognition factor for Pol α (Vishwanatha & Kumble, 1993), while this protein is also reported to be an RNA binding protein, interacting with c-myc (Fillipenko et al., 2004). The binding of annexin A2 to RNA and DNA requires Ca2+. Accordingly, it was thought that DNA and RNA bind to acidic phospholipid binding sites via ionic interaction. Our laboratory has investigated details of annexin A1 binding to RNA and DNA (Hirata & Hirata, 1999; 2002). Annexin A1 purified from rat liver nuclei binds to purine clusters in RNA, while it preferentially binds to pyrimidine clusters in DNA. The size of maximal recognition for binding was around 20-25 nt. Since phospholipids, especially acidic phospholipids such a phosphatidylserine, enhanced DNA and RNA binding, the binding of annexin A1 to RNA and DNA was not due to simple ionic interactions, and the sites for binding to phospholipids and DNA/RNA were distinct. Indeed, the RNA binding site of annexin A2 was reported to be C-D helices of Domain IV (Aukrust et al., 2007), while the consensus sequence for phosphatidylserine binding is proposed to be (R/K)XXXΚ-(B-C helices)-(R/K)XXXXDXXS(D/E) in Domain I and II (Montaville et al., 2002).
Annexins are also reported to interact with ATP and GTP (Bandorowicsz-Pikula & Pikula, 1998), although they do not have consensus sequences for typical ATP binding sites such as Walker A. As seen with annexin A7 that forms ion channels in lipid bilayers, GTP and other nucleotides are thought to regulate Ca2+ gating, and/or Ca2+ dependent membrane trafficking such as exocytosis (Caohuy et al., 1996). Cotton fiber annexin and N-terminal deleted annexin A1 can hydrolyze GTP in the presence of Mg2+, and Ca2+ is not required for this hydrolysis (Hyun et al., 2000; Shin & Brown, 1999). Since annexin A1 can bind not only ssDNA but also dsDNA in the presence of both Mg2+ and Ca2+, we examined effects of various DNAs on ATP hydrolysis by annexin A1 (Hirata & Hirata, 2002). dsDNA such as calf thymus DNA and annealed M13mp18 but not ssDNA stimulated ATP hydrolysis by annexin A1. When DNA was analyzed, dsDNA was unwound to form ssDNA, suggesting that annexin A1 has DNA helicase activity (Hirata & Hirata, 2002). Interestingly, its annealing reaction did not require Mg2+ nor ATP, but Ca2+ was necessary. Therefore, binding of dsDNA requires Mg2+, and that of ssDNA takes place in the presence of Ca2+ (Fig. 1).
5. Modification with SUMOylation and ubiquitination and annexin helicase activity
Purified rat nuclear annexin A1 had an apparent molecular weight of approximately 92,000 ± 2,000 Da, and was ubiquitinated as detected by anti-ubiquitin antibody (A.Hirata et al., 2010). Under reducing conditions, its molecular weight was approximately 45,000 ± 1,000 Da on SDS-PAGE, suggesting that high molecular weight annexin A1 is a homodimer of mono-ubiquitinated annexin A1 rather than a heterodimer complex with S100 as previously thought. Since this homodimer with an apparent molecular weight of 92,000 Da exhibited a Ca2+- and Mg2+-regulated helicase activity, we performed helicase assays of the reaction mixtures for ubiquitination and SUMOylation of annexin A1. The reaction mixtures containing annexin A1 modified with SUMO1 and native annexin A1 showed helicase activity as measured by unwinding of dsDNA. While purified native annexin A1 also exhibited low helicase activity, SUMOylated annexin A1 exhibited much higher activity. Since under the present conditions, approximately 10% and 20% of annexin A1 were modified in the absence and presence of Ca2+ with SUMO1, we calculated that SUMOylation stimulated the helicase activity of annexin A1 by approximately 3.5 fold (F. Hirata et al., 2010).
HeLa S100 lysate that was required for ubiquitination reactions contained other types of helicases beside annexin A1, and thus increased control activity. Despite this challenge, the reaction mixtures containing mono-ubiquitinated annexin A1 demonstrated clearly enhanced helicase activity (F. Hirata et al., 2010). Assuming that annexin A1 in HeLa S100 exhibits helicase activity equal to purified bovine annexin A1, mono-ubiquitination of annexin A1 results in an approximately 6-fold activation as compared with native annexin A1. Since purified rat nuclear annexin A1 shows 9 fold higher activity than native rat annexin A1 (A. Hirata et al., 2010), these observations suggest that the conjugation of annexin A1 with ubiquitin or SUMO enhances its helicase activity.
6. Heavy metals and annexin A1
Annexin A1 has 3 different types of Ca2+ binding sites, type II, type III and type III (AB) (Weng et al., 1993). Type II calcium binding sites have the highest affinity for Ca2+, and are found only at AB loops. The coordination of the type II sites is octahedral. It consists of three peptide oxygens from the AB loops with the (K, R)-(G, R)-X-G-T sequence and bidentate ligands from the acidic groups of either an aspartate or a glutamate residue downstream in the sequence. The remaining two calcium coordinating sites show electro-density for water molecules. The calcium ions at the type III sites coordinate to two backbone carbonyl oxygens and one nearby acidic side chain. Water molecules have been found at most of the remaining three coordinating sites to complete the six-ligand octahedral coordination. The type III sites correspond to the two minor calcium sites labeled by lanthanum in annexin A5.
As seen with EF band calcium binding proteins that have type I Ca2+ binding sites, phospholipid aggregation experiments suggest that other divalent metals such as Pb2+ and Zn2+ can replace Ca2+ in annexin A1 (Mel'gunov et al., 2000). Since type III Ca2+ binding sites can be labeled with La3+, we tested not only Pb2+ and Cd2+ but also As3+ and Cr6+ for DNA helicase assays (A. Hirata et al., 2010). Pb2+ alone stimulated the DNA binding activity of purified mono-ubiquitinated nuclear annexin A1 in the absence of Mg2+ and Ca2+. Heat denatured nuclear annexin A1 did not exert DNA binding even with these metals. Therefore, we thought that Pb2+ and Ca2+ were acting in essentially similar manners on mono-ubiquitinated annexin A1. Similar results were observed with Cd2+, suggesting that these divalent metals were able to replace Ca2+ for DNA binding activity of annexin A1 as previously shown for its phospholipid binding activity (Mel'gunov et al., 2000). To clarify whether carcinogenic heavy metals such as As3+ and Cr6+ can promote or block the DNA binding activity of nuclear annexin A1, we tested the effects of As3+ on binding of nuclear annexin A1 to P0G, a 80mer polynucleotide that is complimentary to the
Ca2+ facilitates the annealing of C20-P0G to M13mp18 by nuclear annexin A1 (Hirata & Hirata, 2002). Although poly(dC)20 was added at the 3’- or at the 5’-end of P0G as a binding site for annexin A1, which demonstrates a higher affinity for poly(dC)20 (Hirata & Hirata, 2002), nuclear annexin A1 bound to P0G without a poly(dC)20 tail. To test the interpretation that As3+ or Cr6+ can replace Ca2+, the annealing activity of nuclear annexin A1 was measured in the presence of As3+ or Cr6+ and the absence of Ca2+ or Mg2+. As expected, As3+ promoted the annealing of P0G to M13m18 by nuclear annexin A1 in a concentration-dependent manner. Half-maximal stimulation was observed at 1.4 μM AsCl3. This concentration was consistent with that required for half maximal binding of ssDNA. Similar results with DNA annealing were obtained with CrO3, PbCl2 and CdCl2, with concentrations for half-maximal annealing approximately 3,30 and 0.1 μM, respectively. Since heat denatured nuclear annexin A1 did not promote DNA annealing even with heavy metals under the present experimental conditions (data not shown), it was concluded that carcinogenic heavy metals As3+ and Cr6+ and divalent metals Pb2+ and Cd2+ can replace Ca2+ for the ssDNA binding and DNA annealing activities of nuclear annexin A1 (A. Hirata et al., 2010).
7. DNA damage and mono-ubiquitinated annexin A1
Mono-ubiquitination of nuclear proteins is mainly involved in tolerance of DNA damage, while SUMOylated nuclear proteins generally function in repair of damaged DNA (Ulrich, 2005). Therefore, we tested nuclear annexin A1 for binding to damaged DNA. We synthesized the 80mer, 5’-GTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGC-GAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCA-3’ (P0G), and 3 addi-tional 80mers, each with a selected single G in position 14, 30 or 37 replaced by 8-oxo-guanosine (8-oxo-G) to model DNA damaged at a specific site by oxidation (A. Hirata et al., 2011). These damaged DNAs were designated as P14G, P30G, and P37G. We previously demonstrated that nuclear annexin A1 binds to ssDNA in a Ca2+-dependent manner, and binding to dsDNA or aggregated DNA occurs in a Mg2+-dependent manner (Hirata & Hirata, 1999; 2002). In the presence of 50 µM Ca2+, mono-ubiquitinated annexin A1 purified from rat liver exhibited higher affinity for damaged DNA, while SUMOylated annexin A1 did not show much of difference in preference. In the presence of 50 μM Ca2+,
Ca2+ induces annexin A1 conformational changes (Shesham et al. 2008). Since As3+ and Cr6+ also bind to the Ca2+ binding sites of annexin A1, we tested As3+ and Cr6+ for damaged DNA binding of mono-ubiquitinated annexin A1. The carcinogenic heavy metals, As3+ and Cr6+, increased the affinity of nuclear annexin A1 for the oxidatively damaged DNA, P30G, but not for undamaged P0G. The
The damaged oligonucleotide-M13mp18 duplexes were also unwound in the presence of Mg2+ and ATP by mono-ubiquitinated annexin A1. ATP was hydrolyzed under these conditions. Unwinding velocities appeared similar for undamaged and damaged DNA. The unwinding of damaged polynucleotide-M13mp18 duplexes was inhibited by Ca2+ and heavy metals as reported previously (Hirata & Hirata, 2002).
8. Translesion DNA synthesis by mono-ubiquitinated annexin A1
Helicases and DNA binding proteins are among the first proteins to encounter sites of DNA damage during transcription and DNA replication. The Werner syndrome protein enhances DNA synthesis during strand replacement of damaged DNA through its helicase activity (Harrigan et al., 2003). To test if mono-ubiquitinated annexin A1 stimulates translesion DNA synthesis, Pol β was used as an error-prone DNA polymerase that bypasses 8-oxo-guanine during DNA replication (Avkin & Livneh, 2002). DNA synthesis was measured by extension of the primer, 5’-TGGTTCACGTAG-3’ annealed to P0G or oxidatively damaged DNA oligonucleotide (P30G) templates. Mono-ubiquitinated annexin A1 and Ca2+ increased DNA replication by approximately 2.6 fold as measured by the synthesis of 80mer, a full size of the template, G30G. When DNA synthesis was terminated at the damaged site, the size of DNA newly synthesized should be around 50 mer. Because ATP is not required for the maximal activation, it was conceivable that mono-ubiquitinated annexin A1 promoted annealing of the primer or stabilized the ssDNA template by binding rather than promoting unwinding. Translesion DNA synthesis was greatly enhanced by mono-ubiquitinated annexin A1, when primer was added separately at low concentrations. The amount of primer required for half maximal DNA synthesis in the presence of nuclear annexin A1 and Ca2+ decreased significantly to 1 pmol from 5 pmol in the absence of annexin A1. These observations suggest that mono-ubiquitinated annexin A1 promoted annealing of primer to template, while this primer was not necessarily the best substrate for nuclear annexin A1 with regards to length and base composition (Hirata & Hirata, 1999). It is noteworthy that even when the primer was annealed to the template prior to the experiments, annexin A1 was able to enhance translesion DNA synthesis by Pol β, suggesting that annexin A1 stabilizes the ssDNA region of the template. Taken together, these observations suggest that mono-ubiquitinated annexin A1 acts as a primer-recognizing protein that anneals primers to templates, a ssDNA binding protein, or both (Jindal & Vishwanatha, 1990). Notably, the amount of mono-ubiquitinated annexin A1 required for maximal DNA synthesis was not a function of Pol β, indicating that annexin A1 did not directly interact with this polymerase.
Given that binding of annexin A1 to damaged DNA was dependent on heavy metals, the effects of heavy metals on translesion DNA synthesis by Pol β was examined directly. The concentrations of metals required for half-maximal activation of DNA synthesis equaled those for half-maximal ssDNA binding. With P30G, Ka values for Ca2+, Pb2+, Cd2+, As3+ and Cr6+ were 12.5, 30, 0.1, 1.4, and 3 μM, respectively, without phosphatidylserine. These values are essentially the same as those observed with these heavy metals for helicase activity.
9. Annexin A1-dependent promotion of translesion DNA synthesis by L lymphoma nuclear extracts
L lymphoma, L5178Y
When L5178Y
10. Summary
Cellular contents of annexin A1 increase in a variety of cancer cells including pancreatic cancer, glioma and hepatoma (Lim & Pervaiz, 2007). Not only precancerous hepatocytes but also proliferative hepatocytes following liver damage express annexin A1, while normal hepatocytes do not. Therefore, annexin A1 is proposed to be a biomarker of cell transformation and/or hyperproliferative state (Masaki et al., 1994). In contrast, some cancer cells such as prostate, breast and esophageal cancers demonstrate downregulation of annexin A1 expression (Lim & Pervaiz, 2007). Transfection of cDNA encoding annexin A1 into some cells alters the MAP kinase pathway
Annexin A1 contains sequence and structural motifs for binding of nucleotides (non-Walker A type), binding of Ca2+ and heavy metals (non-EF hand type II and III ) and DNA and/or RNA (helix-loop or turn-helix). Further, this protein is present in DNA synthesomes, suggesting some roles in the replication machinery. Nuclear annexin A1 is modified with ubiquitin and ubiquitin like molecules, and mono-ubiquitination of annexin A1 increases in response to DNA damage. Mono-ubiquitinated annexin A1 exhibits a helicase activity which has higher affinity for damaged DNA. Since helicases are among the first proteins that encounter damaged sites of DNA, this protein may regulate assembly of proteins required for repair of and tolerance to DNA damage. Mono-ubiquitinated but not SUMOylated nor native annexin A1 stimulates error-prone DNA polymerases such as Pol β with damaged DNA as a template
References
- 1.
Aukrust I. Hollås H. Strand E. Eversen L. Travé G. Flatmark T. Vedeler A. 2007 The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV. Journal of Molecular Biology,368 5 May 2007, EPub Mar 2007),1367 1378 0022-2836 - 2.
Avkin S. Livneh Z. 2002 Efficiency, specificity and DNA polymerase-dependence of translesion replication across the oxidative DNA lesion 8-oxoguanine in human cells. Mutation Research,510 1-2 December 2002),81 90 0027-5107 - 3.
Bandorowicz-Pikula J. Pikula S. 1998 Annexins and ATP in membrane traffic: a comparison with membrane fusion machinery. Acta Biochimica Polonica,45 3 721 733 e0173-4154 X - 4.
Calsou P. Frit P. Bozzato C. Salles B. 1996 Negative interference of metal (II) ions with nucleotide excision repair in human cell-free extracts. Carcinogenesis,17 12 2779 2782 0143-3334 eISSN 1460-2180 - 5.
Caohuy H. Srivastava M. Pollard H. B. 1996 Membrane fusion protein synexin (annexin VII) as a Ca2+/GTP sensor in exocytotic secretion. Proceedings of the National Academy of Sciences USA,93 20 10792 17802 e1091-6490 - 6.
Chen Z. J. Sun L. J. 2009 Nonproteolytic functions of ubiquitin in cell signaling. Molecular Cell,33 3 February 2009)275 286 doi: j.molcel.2009.01. 014 - 7.
Cheung C. W. Gibbons N. Johnson D. W. Nicol D. L. 2010 Silibinin-a promising new treatment for cancer. Anti-Cancer Agents in Medicinal Chemistry,10 3 March 2010),186 195 1871-5206 - 8.
Cui L. Wang Y. Shi Y. Zhang Z. Xia Y. Sun H. Wang S. Chen J. Zhang W. Lu Q. Song L. Wei Q. Zhang R. Wang X. 2007 Overexpression of annexin A1 induced by terephthalic acid calculi in rat bladder cancer. Proteomics,7 22 November 2007),4192 4202 e1615-9861 - 9.
Debret R. El Btaouri H. Duca L. Rahman I. Radke S. Haye B. Sallenave J. M. Antonicelli F. 2003 Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells, FEBS Letters,546 2-3 195 202 0014-5793 - 10.
Filipenko N. R. Mac Leod. T. J. Yoon C. S. Waisman D. M. 2004 Annexin A2 is a novel RNA-binding protein. The Journal of Biological Chemistry,279 10 March 2004),8723 8731 0021-9258 eISSN 1083-351X - 11.
Gerke V. Moss S. E. 2002 Annexins: from structure to function. Physiological Reviews,82 2 April 2002),331 371 0031-9333 eISSN 1522-1210 - 12.
Gill G. 2004 SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes & Development,18 17 September 2004),2046 2059 0890-9369 eISSN 1549-5477 - 13.
Harrigan J. A. Opresko P. L. von Kobbe. C. Kedar P. S. Prasad R. Wilson S. H. Bohr V. A. 2003 The Werner syndrome protein stimulates DNA polymerase beta strand displacement synthesis via its helicase activity. The Journal of Biological Chemistry,278 25 June 2003, EPub Mar 2003),22686 22695 0021-9258 eISSN 1083-351X - 14.
Hicke L. 2001 Protein regulation by monoubiquitin. Nature Reviews/Molecular Cell Biology,2 3 March 2001),195 201 1471-0072 - 15.
Hilgarth R. S. Murphy L. A. Skaggs H. S. Wilkerson D. C. Xing H. Sarge K. D. 2004 Regulation and function of SUMO modification. The Journal of Biological Chemistry,279 52 December 2004, EPub Sept 2004),53899 53902 0021-9258 eISSN 1083-351X - 16.
Hirata A. Corcoran G. B. Hirata F. 2010 Carcinogenic heavy metals replace Ca2+ for DNA binding and annealing activities of mono-ubiquitinated annexin A1 homodimer. Toxicology & Applied Pharmacology,248 1 October 2010, EPub Jul 2010)45 51 0004-1008 X - 17.
Hirata A. Corcoran G. B. Hirata F. 2011 Carcinogenic heavy metals, As3+ and Cr6+, increase affinity of nuclear mono-ubiquitinated annexin A1 for DNA containing 8-oxo-guanosine, and promote translesion DNA synthesis. Toxicology & Applied Pharmacology,252 2 April 2011, EPub Feb 2011),159 164 0004-1008 X - 18.
Hirata A. Hirata F. 1999 Lipocortin (annexin) I heterotetramer binds to purine RNA and pyridine DNA. Biochemical & Biophysical Research Communications,265 1 November 1999),200 204 0000-6291 X - 19.
Hirata A. Hirata F. 2002 DNA chain unwinding and annealing reaction of lipocortin (annexin) I heterotetramer: regulation by Ca2+ and Mg2+. Biochemical & Biophysical Research Communications,291 2 February 2002),205 209 0000-6291 X - 20.
Hirata F. 1998 Annexins (Lipocortins), In: Encyclopedia of Immunology, 2nd ed., Roitt, I.M. and Delves, P.J. Eds.,111 115 Academic Press Ltd.,978-0-12226-765-9 New York - 21.
Hirata F. Matsuda K. Notsu Y. Hattori T. Del Carmine R. 1984 Phosphorylation at tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes, Proceeding of the National Academy of Sciences USA,81 15 August 1984),4717 4721 e1091-6490 - 22.
Hirata F. Thibodeau L. M. Hirata A. 2010 Ubiquitination and SUMOylation of annexin A1 and its helicase activity. Biochimica et Biophysica Acta,1800 9 September 2010, EPub Mar 2010),899 905 0304-4165 - 23.
Honma M. Hayashi M. Shimada H. Tanaka N. Wakuri S. Awogi T. Yamamoto K. I. Kodani N. K. Nishi Y. Nakadate M. Sofuni T. 1999 Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis,14 1 January 1999),5 22 0267-8357 eISSN 1464-3804 - 24.
Hsiang C. H. Tunoda T. Whang Y. E. Tyson D. R. Ornstein D. K. 2006 The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. The Prostate,66 13 September 2006),1413 1424 e1097-0045 - 25.
Huang T. T. D’Andrea A. D. 2006 Regulation of DNA repair by ubiquitylation. Nature Reviews/Molecular Cell Biology,7 5 May 2006),323 334 1471-0072 - 26.
Hyun-L Y. Park Y. M. Na D. S. 2000 ATP and GTP hydrolytic function of N-terminally deleted annexin I. Journal of Biochemistry & Molecular Biology,33 4 289 293 2152-4114 - 27.
Jin Y. H. Clark A. B. Slebos R. J. Al-Refai H. Taylor J. A. Kunkel T. A. Resnick M. A. Gordenin D. A. 2003 Cadmium is a mutagen that acts by inhibiting mismatch repair. Nature Genetics,34 3 July 2003),326 329 1061-4036 - 28.
Jindal H. K. Vishwanatha J. K. 1990 Purification and characterization of primer recognition proteins from HeLa cells. Biochemistry,29 20 May 1990),4767 4773 0006-2960 eISSN 1520-4995 - 29.
Katoh N. Suzuki T. Yuasa A. Miyamoto T. 1995 Distribution of annexin I, II and IV in bovine mammary gland. Journal of Dairy Science,78 11 November 1995),2382 2387 0022-0302 - 30.
Kim Y. S. Ko J. Kim I. S. Jang S. W. Sung H. J. Lee H. J. Kim Y. Na D. S. 2003 PKC delta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate. European Journal of Biochemistry,270 20 October 2003),4089 4094 0022-0302 - 31.
Kumble K. D. Iversen P. L. Vishwanatha J. K. 1992 The role of primer recognition proteins in DNA replication: inhibition of cellular proliferation by antisense oligonucleotides. Journal of Cell Science,101 No.Pt 1, (January 1992),35 41 0021-9533 eISSN 1477-9137 - 32.
Kunz B. A. Straffon A. F. Vonarx E. J. 2000 DNA damage-induced mutation: tolerance via translesion synthesis. Mutation Research,451 1-2 June 2000)169 185 0027-5107 - 33.
Lim L. H. Pervaiz S. 2007 Annexin 1: the new face of an old molecule. The FASEB Journal,21 4 April 2007, Epub Jan 2007),968 975 0014-5793 - 34.
Lin C. Y. Jeng Y. M. Chou H. Y. Hsu H. C. Yuan R. H. Chiang C. P. Kuo M. Y. 2008 Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. Journal of Surgical Oncology,97 6 May 2008),544 550 e1096-9098 - 35.
Lin S. Hickey R. Malkas L. 1997 The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest. Cell Growth & Differentiation,8 No.,1359 1369 1541-7786 eISSN 1557-3125 - 36.
Lin S. Hickey R. J. Malkas L. H. 1997 The isolation of a DNA synthesome from human leukemia cells. Leukemia Research,21 6 June 1997),501 512 0145-2126 - 37.
Liu Y. Wang H. X. Lu N. Mao Y. S. Liu F. Wang Y. Zhang H. R. Wang K. Wu M. Zhao X. H. 2003 Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World Journal Gastroenterology,9 4 645 649 1007-9327 - 38.
Liu Y. C. Yang Z. Y. Du J. Yao X. J. Lei R. X. Zheng X. D. Liu J. N. Hu H. S. Li H. 2008 Study on the interactions of kaempferol and quercetin with intravenous immunoglobulin by fluorescence quenching, fourier transformation infrared spectroscopy and circular dichroism spectroscopy. Chemical & Pharmaceutical Bulletin,56 4 April 2008),443 451 0009-2363 eISSN 1347-5223 - 39.
Maier A. Schumann B. L. Chang X. Talaska G. Puga A. 2002 Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity. Mutation Research,517 1-2 May 2002),101 111 1383-5718 - 40.
Masaki T. Tokuda M. Ohnishi M. Watanabe S. Fujishima T. Miyamoto K. Itano T. Matsui H. Arima K. Shirai M. Maeba T. Sogawa K. Konishi R. Taniguchi K. Hatanaka Y. Hatase O. Nishioka M. 1996 Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Journal of Hepatology,24 1 July 1996),72 81 0168-8278 - 41.
Masaki T. Tokuda M. Fujimura T. Ohnishi M. Tai Y. Miyamoto K. Itano T. Matsui H. Watanabe S. Sogawa K. Yamada T. Konishi R. Nishioka M. Hatase O. 1994 Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Journal of Hepatology,20 2 August 1994),425 435 0168-8278 - 42.
Mel’gunov V. I. Akimova E. I. Krasavchenko K. S. 2000 Effect of divalent metal ions on annexin-mediated aggregation of asolectin liposomes. Acta Biochimica Polonica,47 3 675 683 e0173-4154 X - 43.
Mohiti J. Caswell A. M. Walker J. H. 1997 The nuclear location of annexin V in the human osteosarcoma cell line MG-63 depends on serum factors and tyrosine kinase signaling pathways. Experimental Cell Research,234 1 July 1997),98 104 0014-4827 - 44.
Montaville P. Neumann J. M. Russo-Marrie F. Ochsenbein F. Sanson A. 2002 A new consensus sequence for phosphatidylserine recognition by annexins. The Journal of Biological Chemistry,277 27 July 2002),24684 24693 0021-9258 eISSN 1083-351X - 45.
O’Brien T. J. Witcher P. Brooks B. Patierno S. R. 2009 DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis. Mutation Research,663 1-2 April 2009),77 83 0027-5107 - 46.
Chap, H. (Raydal P. van Bergen en. Henegouwen P. M. Hullin F. Ragab-Thomas J. M. Fauvel J. Verleij 1992 Morphological and biochemical evidence for partial nuclear localization of annexin 1 in endothelial cells. Biochemical & Biophysical Research Communications,186 1 July 1992),432 439 0000-6291 X - 47.
Rhee H. J. Kim G. Y. Huh J. W. Kim S. W. Na D. S. 2000 Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. European Journal of Biochemistry,267 11 June 2000),3220 3225 e1742-4658 - 48.
Sakaguchi M. Murata H. Sonegawa H. Sakaguchi Y. Futami J. Kitazoe M. Yamada H. Huh N. H. 2007 Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. The Journal of Biological Chemistry,282 49 December 2007, Epub Oct 2007),35679 35686 0021-9258 eISSN 1083-351X - 49.
Sekowski J. W. Malkas L. H. Wei Y. Hickey R. J. 1997 Mercuric ion inhibits the activity and fidelity of the human cell DNA synthesome. Toxicology & Applied Pharmacology,145 2 August 1997),268 276 0004-1008 X - 50.
Shesham R. D. Bartolotti L. J. Li Y. 2008 Molecular dynamics simulation studies on Ca2+-induced conformational changes of annexin I. Protein Engineering Design & Selection,21 2 February 2008),115 120 1741-0126 eISSN 1741-0134 - 51.
Shimoji T. Murakami K. Sugiyama Y. Matsuda M. Inubushi S. Nasu J. Shirakura M. Suzuki T. Wakita T. Kishino T. Hotta H. Miyamura T. Shoji I. 2009 Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. Journal of Cellular Biochemistry,106 6 April 2009),1123 1135 e1097-4644 - 52.
Shin H. Brown R. M. Jr 1999 GTPase activity and biochemical characterization of a recombinant cotton fiber annexin. Plant Physiology,119 3 March 1999),925 934 0032-0889 eISSN 1532-2548 - 53.
Skouteris G. G. Schröder C. H. 1996 The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. The Journal of Biological Chemistry,271 44 November 1996),27266 27273 0021-9258 eISSN 1083-351X - 54.
Tavokoli-Nezhad M. Hirata A. Hirata F. 1998 Lipocortin I stimulates the synthesis of the DNA lagging strand. The FASEB Journal,12 A1354,0014-5793 - 55.
Ulrich H. D. 2005 The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO. Chembiochem,6 10 October 2005),1735 1743 e1439-7633 - 56.
Vishwanatha J. Jindal H. K. Davis R. G. 1992 The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells. Journal of Cell Science,101 No.Pt 1, (January 1992),25 34 0021-9533 eISSN 1477-9137 - 57.
Vishwanantha J. K. Kumble S. 1993 Involvement of annexin II in DNA replication: evidence from cell-free extracts of xenopus eggs. Journal of Cell Science,105 No.Pt 2, (June 1993),533 540 0021-9533 eISSN 1477-9137 - 58.
Wang Y. Serfass L. Roy M. O. Wong J. Bonneau A. M. Georges E. 2004 Annexin-I expression modulates drug resistance in tumor cells. Biochemical & Biophysical Research Communications,314 2 February 2004),565 570 0000-6291 X - 59.
Wang Z. 2001 DNA damage-induced mutagenesis: a novel target for cancer prevention. Molecular Interventions,1 5 December 2001),269 281 1534-0384 eISSN 1543-2548 - 60.
Weng X. Lueke H. Song I. S. Kung D. S. Kim S. H. Huber R. 1993 Crystal structure of human annexin I at 2.5 A resolution. Protein Science,2 3 December 2008),448 458 e0146-9896 X - 61.
Wilkinson K. A. Nishimune A. Henley J. M. 2008 Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs. Neuroscience Letters,436 2 May 2008),239 244 0304-3940 - 62.
Yang W. Paschen W. 2009 Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression. Biochemical & Biophysical Research Communications,382 1 April 2009),215 218 0000-6291 X - 63.
Zhu F. Xu C. Jiang Z. Jin M. Wang L. Zeng S. Teng L. Cao J. 2010 Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. The Anatomical Record,293 8 August 2010),1310 1314 e1932-8494